Category Archives: Medicine policy

Indemnity for vaccine manufacturers but not Australians

Typically, the Morrison government has provided indemnity for vaccine manufacturers but not Australians who are at risk of the exceedingly rare, but sometimes fatal, blood clots linked to the AstraZeneca vaccine. A no-fault vaccine injury compensation scheme recognises that if … Continue reading

Posted in Medicine policy | Tagged , , , , , | Leave a comment

Resignation from TGACC

My resignation from the Therapeutic Goods Advertising Consultative Committee (TGACC) was precipitated by the non-response of Adj Professor John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health, to long-standing issues raised yet again at the Skepticon 2020 regulatory … Continue reading

Posted in Advertising, Complementary medicine, Medicine policy, Pharmaceutical Promotion, Regulation | Tagged , , , , , , | Leave a comment

Independent Review of the Therapeutic Goods Advertising Framework: Recommendations

In 2018, the Hon Greg Hunt MP, Minister for Health, committed to a review of the impact of the new therapeutic goods advertising measures within two years from the commencement of the changes to the Therapeutic Goods Act 1989 to … Continue reading

Posted in Advertising, Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , | 4 Comments

Towards independence from commercial interests in health

An important collection of resources from the British Medical Journal (BMJ) Growing evidence shows that extensive financial relationships between industry and healthcare decision makers distort scientific research, medical education and the practice of medicine. The biggest problem is that industry … Continue reading

Posted in Advertising, Education, Medicine policy, Pharmaceutical Promotion, Regulation | Tagged , , , , | Leave a comment

Work Integrated Learning (WIL): Monash BME 2032

Work Integrated Learning (Monash BME 2032) enables students to apply discipline related knowledge to authentic, real-world situations in non-clinical, industry-focused work environments. It also provides opportunities to establish closer links between future graduates and industry partners. This summer, three work … Continue reading

Posted in Choosing wisely, Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

A medical food for depression?

Neurofolin® (containing 15 mg of L-methylfolate calcium) is a self-declared food for special medical purposes promoted for dietary support of depression management. Advertisments claim that L-methylfolate is, “an active form of folate known to be deficient in individuals with depressive … Continue reading

Posted in Advertising, Complementary medicine, Food, Medicine policy | Tagged | 2 Comments

Traditional Chinese Medicine in Australia: Yunnan Baiyao

An illustrative example of products available in Australia from local Chinese outlets. Illegally supplied (no ARTG number), a potentially dangerous ingredient (Aconiti Kusnezoffii Radix), claims that breach numerous section of the Therapeutic Goods Advertising Code (No.2) 2018 (including promoting for … Continue reading

Posted in Complementary medicine, Medicine policy, Natural Therapies | Tagged , , , , , | Leave a comment

Food-medicine interface problems

FSANZ, Consumer and Public Health Dialogue, 27 March 2019, Canberra. I’ve now provided a report of my presentation and the discussion that ensured. Summary The regulation of health claims for foods and complementary medicines is inconsistent; complaint systems are problematic, … Continue reading

Posted in Advertising, Complementary medicine, Food, Medical Devices, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment

Forthcoming SBS Insight program on Vitamins and Supplements

I spent 3 hours with a very pro-supplement audience, being filmed by SBS last night (6/02/2019) . I was surprised by the number of ‘true believers’. I give talks on complementary medicines to U3A classes but I have never found … Continue reading

Posted in Advertising, Complementary medicine, Education, Medicine policy | Tagged , , , , , , , | Leave a comment

TGA’s first comprehensive consumer survey: Results on complementary medicines

During June and July 2018 the Therapeutic Goods Administration (TGA) conducted a survey of Australian adults. It employed a dual sampling methodology: a quota driven population-based sample (Panel) and an Opt-in sample sourced through known TGA contacts, networks and consumer … Continue reading

Posted in Complementary medicine, Education, Medicine policy | Tagged , , , | Leave a comment